Location History:
- Des Moines, WA (US) (2011)
- Seattle, WA (US) (2017 - 2019)
Company Filing History:
3 out of 2,103 
1 out of 1,361 
1 out of 26 
Years Active: 2011-2019
Title: The Innovative Contributions of Stephen R. Plymate in Cancer Research
Introduction: Stephen R. Plymate is a prominent inventor based in Seattle, WA, recognized for his significant contributions to cancer research through innovative therapeutic approaches. With a robust portfolio of three patents, Plymate demonstrates a commitment to enhancing treatment strategies and improving patient outcomes in the field of oncology.
Latest Patents: Plymate's recent patents underscore his dedication to advancing cancer treatment methodologies. The first patent, focusing on "Bumped kinase inhibitor compositions and methods for treating cancer," introduces groundbreaking compositions designed to disrupt cancer cell signaling pathways effectively. The second patent, titled "Identifying taxane sensitivity in prostate cancer patients," offers a novel diagnostic method that allows for the detection of specific androgen receptor splice variants, namely ARv5,6,7, in prostate cancer patients. This advancement aims to tailor taxane treatment based on individual patient biology, thus enhancing treatment efficacy.
Career Highlights: Plymate has had an impactful career, honing his expertise through roles at leading academic institutions, including the University of Washington and Cornell University. His work has not only contributed to the scientific community but has also facilitated the translation of laboratory discoveries into practical applications that benefit patients.
Collaborations: Throughout his career, Plymate has collaborated with notable researchers such as Paraskevi Giannakakou and Wesley C. Van Voorhis, fostering a collaborative environment that amplifies innovation in cancer research. These partnerships have been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.
Conclusion: Stephen R. Plymate's innovative patents and collaborative efforts in cancer research highlight his role as a key contributor to advancements in oncology. His work not only reflects the potential for scientific discovery but also emphasizes the importance of personalized medicine in treating cancer, paving the way for future research and innovations in this critical area.